Headquartered in Buffalo, Vicora is developing the Vibrato thrombectomy system, a catheter with an integrated vibrating distal tip designed for clot removal. The company is the first portfolio company of Egret Healthcare Ventures and is currently in the research and development phase, with its device not yet approved or available for sale.
NeuRx MedicalNeuRx Medical is developing the NeuRx Sweeper™, a low-profile adjunct catheter designed to remove organized, adherent clot during thrombectomy for deep-vein thrombosis and pulmonary embolism. Founded by medical-device commercialization executive Timothy Clark, the company uses a radially expanding nitinol capture node to apply mechanical traction where aspiration alone can leave residual thrombus. The investigational device has completed bench and animal feasibility testing, while NeuRx advances it toward FDA 510(k) clearance.
Chloros Medical LLCChloros Medical LLC is developing technology for disinfecting ultrasound probes. Its technology is in development and is not yet FDA cleared for use.
Rookery LabsRookery Labs operates a Western New York innovation incubator for medical-device research, development, and engineering. Based in Buffalo, the company brings researchers, engineers, and healthcare professionals together while developing medical-technology talent and supporting healthcare ventures. Its quality system is certified to ISO 13485.BUFFALO, NY
Phase TherapeuticsPhase Therapeutics is an Owego medtech startup developing a translumenal ultracold cryoablation platform for treating tumors in inoperable cancer patients. Its approach is designed to deliver cryoablation through flexible endoscopic procedures, including bronchoscopy and endoscopic ultrasound, with real-time visualization. The company’s technologies remain in the preclinical trial stage and are not cleared by the FDA for human use.OWEGO, NY